Figure 4
From: A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it?
Kaplan Meier overall survival: PLD treatment in II line treatment.
Figure 4 | Journal of Ovarian Research
From: A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it?
Kaplan Meier overall survival: PLD treatment in II line treatment.